Oncotelic Therapeutics, Inc. has announced the beta launch of a proprietary SEC chatbot, utilizing their DAO token (PDAO) and Artificial Intelligence (AI). This chatbot…
Oncotelic Therapeutics, Inc. has announced the beta launch of a proprietary SEC chatbot, utilizing their DAO token (PDAO) and Artificial Intelligence (AI). This chatbot…
Login below or Register Now.
Already registered? Login.